about
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and ApplicationSolid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent BreakthroughsDevelopment and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles.Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken designFormulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken designCholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.Design and Evaluation of Voriconazole Loaded Solid Lipid Nanoparticles for Ophthalmic Application.Nanovehicular intracellular delivery systems.Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease.Comparison of drug release from liquid crystalline monoolein dispersions and solid lipid nanoparticles using a flow cytometric techniqueCiprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment.In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate.Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies.Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model.Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells.Modification of composition of a nanoemulsion with different cholesteryl ester molecular species: effects on stability, peroxidation, and cell uptake.Sesamol loaded solid lipid nanoparticles: a promising intervention for control of carbon tetrachloride induced hepatotoxicity.Determination of physicochemical properties and degradation kinetics of triamcinolone acetonide palmitate in vitro.Chitosan nanoparticles for ocular delivery of cyclosporine A.Nanostructured lipid carriers as a delivery system of biochanin A.Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer.Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.Attenuation of carbon tetrachloride-induced hepatic injury with curcumin-loaded solid lipid nanoparticles.Preparation, characterization, and pharmacokinetics of tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles.Formulation, characterisation and in vivo evaluation of lipid-based nanocarrier for topical delivery of diflunisal.Development and Characterization of Solid Lipid Nanoparticles Containing Herbal Extract: In Vivo Antidepressant Activity.Magnetically Directed Targeting Aggregation of Radiolabelled Ferrite NanoparticlesCyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance andIn VivoDrug Release in Rabbit Eyes
P2860
Q26778603-686C72D9-6037-49D7-82FD-AD904A8176D7Q26799879-966B4B61-69AF-41FF-B650-958B8EF776E9Q33986062-3884DBF0-D61D-479B-B880-2798A2C26E4CQ33986082-7ED423B3-7BBD-4BA9-A68B-A6488BD8775EQ34610568-934D172A-D4F6-498F-8316-096CC31A1785Q34733880-482BEC86-FABA-4F0C-B201-02C5E9BEC3CEQ34883416-49CD19D3-366C-4B48-A7C1-8244F9926218Q35796474-F706EE68-5A0E-4B94-846F-0574A44B915BQ36159180-220467C6-FBCC-4D03-AFFD-44C9D80DBAB9Q36583732-2B17367A-D1A4-48BA-8524-B94F86BF5471Q36697414-F1232A3F-1722-4696-BC00-425FE276AB02Q36936716-AAD3C805-FB49-4F23-84A9-B84C4D4FD46AQ37058812-1BC16F17-BA95-477D-8C27-D08A812C1B71Q37763152-0E84FCE7-936E-4917-9C03-BDC4BDD5BA8CQ37914880-E1268E10-D493-4DC7-8682-DD1C6D8C5542Q38242752-77BC1707-2A70-4B9E-9DFC-13025E7A7950Q38406190-2AE16F8A-BA1D-4674-BEBF-F1B775A090F7Q38682342-4E75CC76-DBED-49D5-BDCB-B0DF437EA300Q38950475-8FD28FCA-D067-4FC0-B200-2BAD72AAB3F5Q38963042-C290F10E-2232-4D1E-A2CF-ADF6B5410EF7Q39096524-E1968AE9-8898-4090-A7B7-C942A046329EQ39130500-E0E75A7E-0D65-4ADC-B18B-2A8A28A33098Q39518383-25535F7B-1437-4C1D-BFB1-B20305D18888Q39900986-432F3891-F35A-492B-B801-AF913F4BCFF1Q40761674-9B8B132C-5754-4E42-B7B8-1C0D85AC7A57Q41050086-BC4341C5-1621-4E45-B177-DB9514EC9EE3Q41779474-EBDFB46C-FB0B-4E01-A023-B13238E8EF50Q42081306-87346BFC-DC62-4041-B6A1-90EE24550CA0Q42207073-9968A33C-C3E4-46B3-9EFC-3FCECF9902F9Q43044159-EF9CE482-A75F-4065-A5E2-A58CCAEAF069Q44640830-BA27E88E-2B5E-42BC-AFC3-12756993783AQ45415768-7F36FD12-A09A-45F9-A096-F36D9ED23D77Q46832130-C1FCB0B1-5412-422F-90EC-57BB77888D7CQ47576736-3EB955A7-7ABB-4913-A0B4-4011037BF603Q48345993-88A49E06-8BFB-474B-99CD-4FC4B3CAD1A4Q51788561-738FCDCF-FA34-4D0B-B412-5CF4BB46DE80Q53042232-7E17BB65-6337-4849-9F72-E2113159F1F5Q55476473-9980B811-4ACC-4B5B-993A-21F23E6DA845Q58691173-9436BB6A-F15C-4E4D-9393-40D30FFC5AF8Q59155923-A6DD6A75-400D-45C6-9828-B632283DBE44
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Solid lipid nanoparticles as drug delivery systems.
@ast
Solid lipid nanoparticles as drug delivery systems.
@en
type
label
Solid lipid nanoparticles as drug delivery systems.
@ast
Solid lipid nanoparticles as drug delivery systems.
@en
prefLabel
Solid lipid nanoparticles as drug delivery systems.
@ast
Solid lipid nanoparticles as drug delivery systems.
@en
P2093
P1476
Solid lipid nanoparticles as drug delivery systems.
@en
P2093
Manjunath K
Venkateswarlu V
P304
P356
10.1358/MF.2005.27.2.876286
P577
2005-03-01T00:00:00Z